Matches in Wikidata for { <http://www.wikidata.org/entity/Q91609755> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- Q91609755 description "article scientifique publié en 2019" @default.
- Q91609755 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q91609755 description "scientific article published on 16 April 2019" @default.
- Q91609755 description "wetenschappelijk artikel" @default.
- Q91609755 description "наукова стаття, опублікована 16 квітня 2019" @default.
- Q91609755 name "InCl3 mediated heteroarylation of indoles and their derivatization via CH activation strategy: Discovery of 2-(1H-indol-3-yl)-quinoxaline derivatives as a new class of PDE4B selective inhibitors for arthritis and/or multiple sclerosis" @default.
- Q91609755 name "InCl3 mediated heteroarylation of indoles and their derivatization via CH activation strategy: Discovery of 2-(1H-indol-3-yl)-quinoxaline derivatives as a new class of PDE4B selective inhibitors for arthritis and/or multiple sclerosis" @default.
- Q91609755 type Item @default.
- Q91609755 label "InCl3 mediated heteroarylation of indoles and their derivatization via CH activation strategy: Discovery of 2-(1H-indol-3-yl)-quinoxaline derivatives as a new class of PDE4B selective inhibitors for arthritis and/or multiple sclerosis" @default.
- Q91609755 label "InCl3 mediated heteroarylation of indoles and their derivatization via CH activation strategy: Discovery of 2-(1H-indol-3-yl)-quinoxaline derivatives as a new class of PDE4B selective inhibitors for arthritis and/or multiple sclerosis" @default.
- Q91609755 prefLabel "InCl3 mediated heteroarylation of indoles and their derivatization via CH activation strategy: Discovery of 2-(1H-indol-3-yl)-quinoxaline derivatives as a new class of PDE4B selective inhibitors for arthritis and/or multiple sclerosis" @default.
- Q91609755 prefLabel "InCl3 mediated heteroarylation of indoles and their derivatization via CH activation strategy: Discovery of 2-(1H-indol-3-yl)-quinoxaline derivatives as a new class of PDE4B selective inhibitors for arthritis and/or multiple sclerosis" @default.
- Q91609755 P1433 Q91609755-35F7D791-DBD5-41D5-82FE-84A27AFB9A35 @default.
- Q91609755 P1476 Q91609755-F340F383-DA37-4159-AEF4-3A3ADA15D759 @default.
- Q91609755 P2093 Q91609755-11C46858-86ED-471A-88E2-2323B97681DF @default.
- Q91609755 P2093 Q91609755-1B916923-BD70-41F3-A59D-3B9B1ED4B0B1 @default.
- Q91609755 P2093 Q91609755-2E74034F-B52E-4C82-AF53-9D58B2BCAD16 @default.
- Q91609755 P2093 Q91609755-366DA39C-06B6-465C-B6F5-A01A8AC0E68A @default.
- Q91609755 P2093 Q91609755-43344463-9D9B-466C-9C77-813C5BFDCBFF @default.
- Q91609755 P2093 Q91609755-6C97781B-C15D-4DF9-B390-220E365D5987 @default.
- Q91609755 P2093 Q91609755-7464E558-B07F-4590-BDF9-3BF394B772E3 @default.
- Q91609755 P2093 Q91609755-7C201076-D625-47FC-8174-FB10ADDAD228 @default.
- Q91609755 P2093 Q91609755-80FAA044-B662-4E19-B09E-1C71C0E01C5B @default.
- Q91609755 P2093 Q91609755-9F74E653-B98F-4145-9BCD-BE3E3C75D8B6 @default.
- Q91609755 P2093 Q91609755-BADC3B2A-7646-4D6F-9220-B2381B6F8E02 @default.
- Q91609755 P2093 Q91609755-C2CED456-0C1C-423E-88E2-7A04B5D078A0 @default.
- Q91609755 P2093 Q91609755-E14D3C0C-C637-46F3-8490-C9660E6F761B @default.
- Q91609755 P2093 Q91609755-E3658EED-4C5F-4F5A-84CB-6E5040B8892C @default.
- Q91609755 P2093 Q91609755-EF48D41C-75C3-449F-B9BD-8CD42B42DA08 @default.
- Q91609755 P304 Q91609755-5337422C-36AA-46B1-B83C-56D29566BC01 @default.
- Q91609755 P31 Q91609755-72747613-0D91-4C9F-A266-2600F7ABEC98 @default.
- Q91609755 P356 Q91609755-76F57A49-0551-4EF9-9726-BFDD842B585A @default.
- Q91609755 P478 Q91609755-D2053054-1D73-49D4-A74E-27BE7C9B65B2 @default.
- Q91609755 P577 Q91609755-D929265C-EA55-436D-A0B6-73C2F48A9400 @default.
- Q91609755 P698 Q91609755-2E398AB2-145A-4FE9-A7CC-410D0F5311D9 @default.
- Q91609755 P356 J.EJMECH.2019.04.020 @default.
- Q91609755 P698 31035240 @default.
- Q91609755 P1433 Q3008624 @default.
- Q91609755 P1476 "InCl3 mediated heteroarylation of indoles and their derivatization via CH activation strategy: Discovery of 2-(1H-indol-3-yl)-quinoxaline derivatives as a new class of PDE4B selective inhibitors for arthritis and/or multiple sclerosis" @default.
- Q91609755 P2093 "B Thirupataiah" @default.
- Q91609755 P2093 "E V V Shivaji Ramarao" @default.
- Q91609755 P2093 "Gautham G Shenoy" @default.
- Q91609755 P2093 "Hari Maduri Doss" @default.
- Q91609755 P2093 "Jayesh Mudgal" @default.
- Q91609755 P2093 "Jessy E Mathew" @default.
- Q91609755 P2093 "Jetta Sandeep Kumar" @default.
- Q91609755 P2093 "Kishore V L Parsa" @default.
- Q91609755 P2093 "Mahaboobkhan Rasool" @default.
- Q91609755 P2093 "Manojit Pal" @default.
- Q91609755 P2093 "Pushkar Kulkarni" @default.
- Q91609755 P2093 "Raghavender Medishetti" @default.
- Q91609755 P2093 "Rajnikanth Sunke" @default.
- Q91609755 P2093 "Ramudu Bankala" @default.
- Q91609755 P2093 "Ravi Kumar Kapavarapu" @default.
- Q91609755 P304 "198-215" @default.
- Q91609755 P31 Q13442814 @default.
- Q91609755 P356 "10.1016/J.EJMECH.2019.04.020" @default.
- Q91609755 P478 "174" @default.
- Q91609755 P577 "2019-04-16T00:00:00Z" @default.
- Q91609755 P698 "31035240" @default.